PMA supplement
P980022 S124: CARELINK IPRO THERAPY MANAGEMENT SOFTWARE
FDA PMA supplement · Real-Time Process · Medtronic Minimed
Key facts
| Original PMA | P980022 |
|---|---|
| Supplement number | S124 |
| Supplement type | Real-Time Process |
| Reason for the supplement | Change Design/Components/Specifications/Material |
| Trade name | CARELINK IPRO THERAPY MANAGEMENT SOFTWARE |
| Generic name | Sensor, glucose, invasive |
| Applicant | Medtronic Minimed |
| Product code | MDS |
| Received date | Sep 18, 2012 |
| Decision date | Nov 16, 2012 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: